Potential use of visible and near-infrared spectroscopy for the analysis and diagnosis of chronic fatigue syndrome (Review)

Sakudo,Akikazu

doi:10.3892/mmr.2016.5476

Potential use of visible and near-infrared spectroscopy for the analysis and diagnosis of chronic fatigue syndrome (Review)

Authors:
- Akikazu Sakudo
View Affiliations

Affiliations: Laboratory of Biometabolic Chemistry, School of Health Sciences, Faculty of Medicine, University of The Ryukyus, Nishihara, Okinawa 903‑0215, Japan
Published online on: July 7, 2016 https://doi.org/10.3892/mmr.2016.5476
Pages: 1875-1879

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

At present, chronic fatigue syndrome (CFS) is diagnosed on the basis of clinical symptoms. Although various psychological, endocrinological and immunological abnormalities of patients with CFS have been reported, no clear consensus exists regarding the symptoms for this disorder. Thus, an objective diagnostic method for CFS is urgently required. The present study investigated the diagnosis and analysis of CFS using visible and near‑infrared (Vis‑NIR) spectroscopy. Previous studies have demonstrated the potential of Vis-NIR spectroscopy for diagnosing CFS by analyzing either serum samples as an invasive approach or thumbs as a non‑invasive approach. Analysis of the Vis‑NIR spectra of blood and thumbs suggested that factors absorbing in this spectral region are altered in patients with CFS compared with healthy individuals. These findings are likely to facilitate the search for biomarkers associated with CFS and to increase our understanding of the pathophysiology of the disorder. The current review aimed to outline the latest studies and discuss the future perspectives for CFS made possible by Vis-NIR spectroscopy.

View Figures

View References

1	Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG and Komaroff A: The chronic fatigue syndrome: A comprehensive approach to its definition and study. International chronic fatigue syndrome study group. Ann Intern Med. 121:953–959. 1994. View Article : Google Scholar : PubMed/NCBI
2	Bested AC, Logan AC and Howe R: Hope and Help for Chronic Fatigue Syndrome and Fibromyalgia. Cumberland House; Nashville, TN: 2008
3	Jason LA, Richman JA, Rademaker AW, Jordan KM, Plioplys AV, Taylor RR, McCready W, Huang CF and Plioplys S: A community-based study of chronic fatigue syndrome. Arch Intern Med. 159:2129–2137. 1999. View Article : Google Scholar : PubMed/NCBI
4	Kuratsune H: Overview of chronic fatigue syndrome focusing on prevalence and diagnostic criteria. Nihon Rinsho. 65:983–990. 2007.In Japanese. PubMed/NCBI
5	Reynolds KJ, Vernon SD, Bouchery E and Reeves WC: The economic impact of chronic fatigue syndrome. Cost Eff Resour Alloc. 2:42004. View Article : Google Scholar : PubMed/NCBI
6	Reyes M, Nisenbaum R, Hoaglin DC, Unger ER, Emmons C, Randall B, Stewart JA, Abbey S, Jones JF, Gantz N, et al: Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med. 163:1530–1536. 2003. View Article : Google Scholar : PubMed/NCBI
7	Vernon SD, Whistler T, Aslakson E, Rajeevan M and Reeves WC: Challenges for molecular profiling of chronic fatigue syndrome. Pharmacogenomics. 7:211–218. 2006. View Article : Google Scholar : PubMed/NCBI
8	Wold S: Pattern Recognition by means of disjoint principal components models. Pattern Recognition. 8:127–139. 1976. View Article : Google Scholar
9	Coomans D, Broeckaert I, Derde MP, Tassin A, Massart DL and Wold S: Use of a microcomputer for the definition of multivariate confidence regions in medical diagnosis based on clinical laboratory profiles. Comput Biomed Res. 17:1–14. 1984. View Article : Google Scholar : PubMed/NCBI
10	Sakudo A, Kuratsune H, Kobayashi T, Tajima S, Watanabe Y and Ikuta K: Spectroscopic diagnosis of chronic fatigue syndrome by visible and near-infrared spectroscopy in serum samples. Biochem Biophys Res Commun. 345:1513–1516. 2006. View Article : Google Scholar : PubMed/NCBI
11	Sakudo A, Kuratsune H, Kato YH and Ikuta K: Visible and near-infrared spectra collected from the thumbs of patients with chronic fatigue syndrome for diagnosis. Clin Chim Acta. 413:1629–1632. 2012. View Article : Google Scholar : PubMed/NCBI
12	Sakudo A, Hakariya Y, Kobayashi T, Sugimoto A and Ikuta K: Possible application of visible and near-infrared spectral patterns in serum to provide emerging clue to biomarkers for chronic fatigue syndrome. J IiME. 2:4–7. 2008.
13	Patarca R: Cytokines and chronic fatigue syndrome. Ann NY Acad Sci. 933:185–200. 2001. View Article : Google Scholar
14	Vernon SD and Reeves WC: Evaluation of autoantibodies to common and neuronal cell antigens in Chronic Fatigue Syndrome. J Autoimmune Dis. 2:52005. View Article : Google Scholar : PubMed/NCBI
15	Nijs J and De Meirleir K: Impairments of the 2-5A synthetase/RNase L pathway in chronic fatigue syndrome. In vivo. 19:1013–1021. 2005.PubMed/NCBI
16	Cleare AJ: The neuroendocrinology of chronic fatigue syndrome. Endocr Rev. 24:236–252. 2003. View Article : Google Scholar : PubMed/NCBI
17	Allain TJ, Bearn JA, Coskeran P, Jones J, Checkley A, Butler J, Wessely S and Miell JP: Changes in growth hormone, insulin, insulinlike growth factors (IGFs), and IGF-binding protein-1 in chronic fatigue syndrome. Biol Psychiatry. 41:567–573. 1997. View Article : Google Scholar : PubMed/NCBI
18	Kuratsune H, Yamaguti K, Takahashi M, Misaki H, Tagawa S and Kitani T: Acylcarnitine deficiency in chronic fatigue syndrome. Clin Infect Dis. 18(Suppl 1): S62–S67. 1994. View Article : Google Scholar : PubMed/NCBI
19	Jacobson W, Saich T, Borysiewicz LK, Behan WM, Behan PO and Wreghitt TG: Serum folate and chronic fatigue syndrome. Neurology. 43:2645–2647. 1993. View Article : Google Scholar : PubMed/NCBI
20	Werbach MR: Nutritional strategies for treating chronic fatigue syndrome. Altern Med Rev. 5:93–108. 2000.PubMed/NCBI
21	Maes M, Mihaylova I and De Ruyter M: Lower serum zinc in Chronic Fatigue Syndrome (CFS): Relationships to immune dysfunctions and relevance for the oxidative stress status in CFS. J Affect Disord. 90:141–147. 2006. View Article : Google Scholar
22	Whiteside TL and Friberg D: Natural killer cells and natural killer cell activity in chronic fatigue syndrome. Am J Med. 105(Suppl): 27S–34S. 1998. View Article : Google Scholar : PubMed/NCBI
23	Curriu M, Carrillo J, Massanella M, Rigau J, Alegre J, Puig J, Garcia-Quintana AM, Castro-Marrero J, Negredo E, Clotet B, et al: Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome. J Transl Med. 11:682013. View Article : Google Scholar : PubMed/NCBI
24	Parker AJ, Wessely S and Cleare AJ: The neuroendocrinology of chronic fatigue syndrome and fibromyalgia. Psychol Med. 31:1331–1345. 2001. View Article : Google Scholar : PubMed/NCBI
25	Morris G, Anderson G, Galecki P, Berk M and Maes M: A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior. BMC Med. 11:642013. View Article : Google Scholar : PubMed/NCBI
26	Morris G, Berk M, Galecki P, Walder K and Maes M: The neuro-immune pathophysiology of central and peripheral fatigue in systemic immune-inflammatory and neuro-immune diseases. Mol Neurobiol. 53:1195–1219. 2016. View Article : Google Scholar
27	Dell'Osso L, Bazzichi L, Baroni S, Falaschi V, Conversano C, Carmassi C and Marazziti D: The inflammatory hypothesis of mood spectrum broadened to fibromyalgia and chronic fatigue syndrome. Clin Exp Rheumatol. 33(1 Suppl 88): S109–S116. 2015.PubMed/NCBI
28	Nijs J, Nees A, Paul L, De Kooning M, Ickmans K, Meeus M and Van Oosterwijck J: Altered immune response to exercise in patients with chronic fatigue syndrome/myalgic encephalomyelitis: A systematic literature review. Exerc Immunol Rev. 20:94–116. 2014.PubMed/NCBI
29	Sakudo A, Hakariya Y, Kobayashi T and Ikuta K: Visible and near-infrared (Vis-NIR) spectroscopy: Introduction and perspectives for diagnosis of chronic fatigue syndrome. J IiME. 1:8–18. 2007.
30	Heise HM: Applications of near-infrared spectroscopy in medical sciences. Near-infrared Spectroscopy: Principles, Instruments, Applications. Siesler HW, Ozaki Y, Kawata S and Heise HM: Wiley-VCH; Weinheim: pp. 289–333. 2002
31	Matsunaga A, Nomura Y, Kuroda S, Tamura M, Nishihira J and Yoshimura N: Energy-dependent redox state of heme a + a3 and copper of cytochrome oxidase in perfused rat brain in situ. Am J Physiol. 275:C1022–C1030. 1998.PubMed/NCBI
32	Hoshi Y, Hazeki O and Tamura M: The oxygen dependency of the redox state of heme and copper in cytochrome oxidase in vitro. Adv Exp Med Biol. 248:71–76. 1989. View Article : Google Scholar : PubMed/NCBI
33	Sakudo A, Kato YH, Tajima S, Kuratsune H and Ikuta K: Visible and near-infrared spectral changes in the thumb of patients with chronic fatigue syndrome. Clin Chim Acta. 403:163–166. 2009. View Article : Google Scholar : PubMed/NCBI
34	Stuart B: Biological Applications of Infrared Spectroscopy. John Wiley & Sons Ltd; New York: 1997
35	Sakudo A, Kuratsune H, Kato YH and Ikuta K: Secondary structural changes of proteins in fingernails of chronic fatigue syndrome patients from Fourier-transform infrared spectra. Clin Chim Acta. 402:75–78. 2009. View Article : Google Scholar : PubMed/NCBI
36	Simick MK, Jong R, Wilson B and Lilge L: Non-ionizing near-infrared radiation transillumination spectroscopy for breast tissue density and assessment of breast cancer risk. J Biomed Opt. 9:794–803. 2004. View Article : Google Scholar : PubMed/NCBI
37	Liu KZ, Shi M, Man A, Dembinski TC and Shaw AR: Quantitative determination of serum LDL cholesterol by near-infrared spectroscopy. Vib Spectrosc. 38:203–208. 2005. View Article : Google Scholar
38	Robinson MR, Eaton RP, Haaland DM, Koepp GW, Thomas EV, Stallard BR and Robinson PL: Noninvasive glucose monitoring in diabetic patients: A preliminary evaluation. Clin Chem. 38:1618–1622. 1992.PubMed/NCBI
39	Gabriely I, Wozniak R, Mevorach M, Kaplan J, Aharon Y and Shamoon H: Transcutaneous glucose measurement using near-infrared spectroscopy during hypoglycemia. Diabetes Care. 22:2026–2032. 1999. View Article : Google Scholar : PubMed/NCBI
40	Hock C, Villringer K, Müller-Spahn F, Hofmann M, Schuh-Hofer S, Heekeren H, Wenzel R, Dirnagl U and Villringer A: Near infrared spectroscopy in the diagnosis of Alzheimer's disease. Ann N Y Acad Sci. 777:22–29. 1996. View Article : Google Scholar : PubMed/NCBI
41	Watanabe E, Nagahori Y and Mayanagi Y: Focus diagnosis of epilepsy using near-infrared spectroscopy. Epilepsia. 43(Suppl 9): 50–55. 2002. View Article : Google Scholar : PubMed/NCBI
42	Sokol DK, Markand ON, Daly EC, Luerssen TG and Malkoff MD: Near infrared spectroscopy (NIRS) distinguishes seizure types. Seizure. 9:323–327. 2000. View Article : Google Scholar : PubMed/NCBI
43	Hazen KH, Arnold MA and Small GW: Measurement of glucose and other analytes in undiluted human serum with near-infrared transmission spectroscopy. Anal Chim Acta. 371:255–267. 1998. View Article : Google Scholar
44	Kobayashi T, Kato YH, Tsukamoto M, Ikuta K and Sakudo A: Portable visible and near-infrared spectrophotometer for triglyceride measurements. Int J Mol Med. 23:75–79. 2009.
45	Sakudo A, Kato YH, Kuratsune H and Ikuta K: Non-invasive prediction of hematocrit levels by portable visible and near-infrared spectrophotometer. Clin Chim Acta. 408:123–127. 2009. View Article : Google Scholar : PubMed/NCBI